SHIMMER PARTNERS WITH HARVARD'S WYSS
INSTITUTE TO ADVANCE THE FIELD OF REMOTE PATIENT MONITORING USING WEARABLE
SENSING TECHNOLOGY
DUBLIN, 13 June 2016 - Shimmer Sensing, a
leading provider of medical grade wearable wireless sensors, announced today a
partnership with the Wyss Institute for Biologically Inspired Engineering at
Harvard University in support of ongoing research focused on remote patient
monitoring using wearable sensing technology. The research is led by Paolo
Bonato, Ph.D., who is an Associate Faculty Member at the Wyss Institute and an
Associate Professor in the Department of Physical Medicine and Rehabilitation
at Harvard Medical School.
"Partnering with Shimmer Sensing will
allow us to further develop our remote patient monitoring platform called
MercuryLive," said Bonato.
MercuryLive is a platform designed to
support clinicians’ remote monitoring of patients – who, for example, could
have Parkinson’s disease or be stroke survivors, traumatic brain injury
survivors, or children with cerebral palsy – via live streaming of wearable sensor
data and an interactive video feed. Bonato’s team at the Wyss Institute is
developing the latest version of the MercuryLive platform, which enables the
integration of a variety of wireless devices.Shimmer’s financial support of the
research and its technical expertise in wireless medical sensors will
accelerate the development of MercuryLive towards applications in remote
patient monitoring. Among other clinical applications, the platform being
developed will allow clinicians to remotely monitor patients with knee
osteoarthritis using a knee sleeve with embedded wireless sensors and observe
older adults in their home using wearable sensors and a mobile robot designed
to navigate the environment and reach the subject in case of an emergency.
“The Wyss Institute
is renowned for taking academic innovation to the next level, and partnering
with physicians and the industry to bring new technologies to the bedside. We
are very enthusiastic about the opportunity to support Prof. Bonato's research
team and their work toward the development of the next generation of remote
clinical monitoring systems,” commented Patrick White, the CEO of Shimmer
Sensing.
“Wearable
patient monitoring systems represent the future of ambulatory medicine, and we
are excited to help catalyze collaborations between engineers, clinicians and
industrial partners to make this a reality,” said Wyss Institute Founding
Director Donald Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of
Vascular Biology at Boston Children's Hospital and Harvard Medical School and
Professor of Bioengineering at the Harvard John A. Paulson School of
Engineering and Applied Science.
